Open Book Extracts Expands Business Development and Regulatory Team to Support European Growth and Distribution Efforts

3.3 min readPublished On: January 19th, 2022By

ROXBORO, N.C. – Open Book Extracts (OBX), a cGMP-certified manufacturer and distributor of the industry’s quality cannabinoid ingredients and finished products, announced the addition of Tony Reeves and Tony Scanlan to its European sales and leadership team. Together with OBX’s global sales and operations teams, Reeves and Scanlan will work to support OBX’s growing list of clients in the United Kingdom and Europe, as well as key global markets around the world.

In March 2021, OBX became a member of the European Industrial Hemp Associations’s (EIHA) Novel Food Consortium, joining forces with other companies to pursue safety studies to provide safe and ready access to cannabinoid-based products throughout the UK and EU. In November 2021, OBX announced the establishment of OBX Europe, with local leadership from Najeeb Qazizada, Director of Supply Chain for OBX Europe. With its main distribution center in the Netherlands, OBX Europe supports local warehousing of OBX ingredients and finished goods in Europe to create supply chain efficiencies for OBX’s UK and European clients, as well as offers additional options for contract manufacturing in the UK and Europe.

OBX announces the appointment of Tony Reeves and Tony Scanlan to the OBX Europe team:

Tony Reeves combines a science background with in-depth product knowledge, extensive networks and commercial insight to drive the discussion on the benefits of Hemp, CBD and other cannabinoids to a diverse audience across the public and private sectors. Since 2015, he has been representing the industry to regulators (MHRA, Home Office, FSA, HPRA, FSAI) and contributing to presentations at the European level on key issues including novel food regulations, CBD and THC levels in food, food supplements, beverages and cosmetics. Reeves serves as a Board Director & UK Representative of the European Industrial Hemp Association (EIHA; the only pan-European hemp trades association (https://eiha.org/) and a consultant to The Hut Group (THG); one of the world’s fastest growing and largest online retailers (www.thg.com). He is member of UKAS-led ‘CBD Food Product Approval Expert Group’ which includes participants from the FSA and the Home Office and a member of the Food & Drink Federation’s (FDF) ‘CBD Working Group.’ In previous roles, Reeves was a consultant to Pyxus International/FIGR Brands Europe and  European Managing Director for  Aurora Hemp, and he holds an MBA from Warwick Business School.

Tony Scanlan possesses a lifetime of experience in the international commercial arena. He has built businesses and partnerships across the UK, USA, EU, Middle EastAfrica and China. Scanlan has been at the forefront of developing retail and consumer products in the CBD, Vape and Telecommunications worlds, quickly understanding the opportunities in emerging sectors then developing appropriate partnerships, brands and product solutions. The regulatory environment has a critical influence on shaping products and partnerships in these sectors, and Scanlan has a long history of teaming up with regulatory experts to ensure that partner and stakeholder strategies are always at the leading edge.

“At OBX, we see international markets as major opportunities to accelerate our  growth with the most promising commercial developments coming out of Europe,” said Dave Neundorfer, OBX CEO. “Investing in experts like Tony Reeves and Tony Scanlan, who bring industry experience, deep strategic relationships, and an innovation mindset, is key to realizing the potential of the European market.”

With a 76,000 sf, cGMP-certified research and production facility near Durham, North Carolina, OBX has developed proven methods to efficiently manufacture a broad range of cannabinoids from hemp and natural sources, including CBD, CBN, CBC, CBG, CBGa, CBT, CBDa, CBDv, and THCv. OBX offers concept-to-market formulation and product development services, leveraging leading water soluble technology and unique delivery mechanisms to help its clients bring to market a wide range of finished goods, from core softgels, capsules, and gummies, to orally dissolving tablets, tongue strips, and aerosol sprays.

(This information is primarily sourced from Open Book Extracts Europe.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • MariMed Inc.

MariMed Strengthens Executive Leadership Team

May 12th, 2022|

NORWOOD, Mass. - MariMed Inc. (OTCQX: MRMD), a multi-state cannabis operator focused on improving lives every day, today announced the appointment of Jon Levine to the new role of Chief Administration Officer and the appointment ...